ritobegron

Known as: (4-(2-(((1R,2S)-1-Hydroxy-1-(4-Hydroxyphenyl)Propan-2-Yl)Amino)Ethyl)-2,5-Dimethylphenoxy)Acetic Acid, 2-(4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-2,5-dimethylphenyloxy)acetic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2016
02420122016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
We evaluated the effects of probenecid, a potent organic anion transporter 1 (OAT1) and OAT3 inhibitor, on the pharmacokinetics… (More)
Is this relevant?
Review
2016
Review
2016
β3-Adrenoceptor agonists were originally considered as a promising drug class for the treatment of obesity and/or type 2 diabetes… (More)
Is this relevant?
Review
2016
Review
2016
INTRODUCTION Drugs which prevent acetylcholine mediated involuntary detrusor contractions are the mainstay of overactive bladder… (More)
Is this relevant?
Review
2016
Review
2016
INTRODUCTION Urinary incontinence in men is a significant and often underappreciated problem. Men can have urgency and or stress… (More)
Is this relevant?
2015
2015
Ritobegron, a selective β3-adrenoceptor agonist, is the prodrug of the active compound, KUC-7322. We investigated species… (More)
Is this relevant?
Review
2015
Review
2015
INTRODUCTION Antimuscarinic drugs form the mainstay of medical treatment for Overactive bladder Syndrome (OAB). With a proven… (More)
Is this relevant?
2014
2014
The pharmacokinetic profile of ritobegron, a novel, selective β3-adrenoceptor agonist, was investigated in rats. Ritobegron, an… (More)
Is this relevant?
2012
2012
We performed in vitro and in vivo experiments to evaluate the pharmacological profile of ritobegron and its effects on the… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
We evaluated the pharmacological profile of ritobegron [KUC-7483; (-)-ethyl 2-[4-(2-{[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1… (More)
  • figure 3
  • table 1
  • figure 4
  • table 2
  • figure 6
Is this relevant?
2012
2012
The objective of this study was to investigate the effects of the β3-adrenoceptor (AR) agonist ritobegron on rat bladder function… (More)
Is this relevant?